ST
HURA

Sabal Trust’s TuHURA Biosciences HURA Stock Holding History

Sabal Trust’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$127K Buy
+39,427
New +$146K 0.01% 230

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabal Trust's HURA Position: Q1 2025 in Review

Sabal Trust opened a new position in TuHURA Biosciences (HURA) in Q1 2025: 39,427 shares worth $127K. The stake represents 0.01% of the portfolio and ranks #230 among its holdings.

27 funds tracked by Wall St. Rank hold HURA as of Q1 2025.

  • Sabal Trust held 39,427 shares of TuHURA Biosciences worth $127K as of Q1 2025.
  • TuHURA Biosciences was a new Sabal Trust position in Q1 2025.
  • TuHURA Biosciences made up 0.01% of Sabal Trust's portfolio in Q1 2025, its #230 holding.
  • 27 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2025.

Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.